Navigation Links
Akorn, Inc. Announces Second Quarter 2011 Earnings Release and Conference Call Information
Date:6/23/2011

LAKE FOREST, Ill., June 23, 2011 /PRNewswire/ -- Akorn, Inc. (NASDAQ: AKRX) will host a conference call on Tuesday, August 2, 2011, to discuss second quarter 2011 results followed by a Q&A session.  The company will release earnings the same day before the market opens. Subject:

Akorn Second Quarter 2011 Conference CallDate/Time:

Tuesday, August 2, 2011, at 10:00 a.m. Eastern TimeDomestic Callers:

(800) 835-9927International Callers:

(913) 312-0831Confirmation Code:

6254677URL For Webcast:

http://www.videonewswire.com/event.asp?id=80562A live broadcast of Akorn's conference call will also be available online at www.akorn.com under the investor relations tab on August 2, 2011, beginning at 10:00 a.m. (Eastern Time).  The online replay will follow immediately and will be available for 30 days.  

About Akorn, Inc.Akorn, Inc. is a niche pharmaceutical company engaged in the development, manufacture and marketing of multisource and branded pharmaceuticals.  Akorn has manufacturing facilities located in Decatur, Illinois and Somerset, New Jersey where the Company manufactures ophthalmic and injectable pharmaceuticals.  Additional information is available on the Company's website at www.akorn.com.


'/>"/>

SOURCE Akorn, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Akorn, Inc. Announces Third Quarter 2010 Earnings Release and Conference Call Information
2. CORRECTED - Akorn, Inc. Announces Date Change for Third Quarter 2010 Earnings Release and Conference Call
3. Akorn, Inc. Announces First Quarter 2011 Earnings Release and Conference Call Information
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)...  Arcturus Therapeutics, Inc. ("Arcturus" or the "Company"), ... it entered into collaboration with Takeda Pharmaceutical Company ... of NASH and other gastrointestinal (GI) related disorders, ... UNA Oligomer chemistry. The financial terms were not ... and expertise in GI disorders, we are confident ...
(Date:12/6/2016)... , Dec. 6, 2016 A new study ... of 340B (AIR 340B) projects the 340B Drug Pricing Program ... by which time it is expected to exceed $23 billion ... would see 340B purchases surpass current Medicare Part B drug ... The new study – based on analysis of data on ...
(Date:12/6/2016)... Tenn , Dec. 6, 2016  In response ... dependent on opioids every 25 minutes, a respected group ... company that will provide a holistic suite of services ... Based on his own experience trying to ... social entrepreneur Justin Lanning launched 180 ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... December 07, 2016 , ... ... that its fully redesigned website, which launched October 17, 2016, features comprehensive information ... design and easy-to-navigate layout. Visitors and patients can discover the latest clinical dermatology ...
(Date:12/7/2016)... , ... December 07, 2016 , ... The medical profession ... and winter seasons. One major study analyzing heart attacks among 138,602 people recorded ... of a given year. We would all agree of course–no time of year is ...
(Date:12/7/2016)... ... ... “The Road To Restoration”: an informative and enlightening book for those who believe ... hands. “The Road To Restoration” is the creation of published author, Thomas Fitzhugh Sheets, ... that you could reach out for, and grab, on the old carousels. If ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... fifth annual Business Architecture Innovation Summit in Reston, VA on March 21-22, 2017. ... will share a range of experiences from a cross-section of industries such as ...
(Date:12/6/2016)... (PRWEB) , ... December 06, 2016 , ... ... have agreed to collaborate in developing a vaccine against the Middle East Respiratory ... vaccine can be available in South Korea for emergency deployment in the event ...
Breaking Medicine News(10 mins):